Ryoji Tominaga, Tatsuyoshi Ikenoue, Ryosuke Ishii, Kakuya Niihata, Tetsuro Aita, Tadahisa Okuda, Sayaka Shimizu, Masataka Taguri, Noriaki Kurita. Comparative cardiovascular safety of romosozumab versus bisphosphonates in Japanese patients with osteoporosis A new-user, active comparator design with instrumental variable analyses. 2024
Sasaki Sho, Shimizu Sayaka, Nakaya Izaya, Miyaoka Yoshitaka, Koizumi Masahiro, Nishiwaki Hiroki, Sofue Tadashi, Ishimoto Takuji, Kurita Noriaki†, Wada Takehiko† (†co-last authors). Preference for anti-phospholipase A2 receptor antibody assay in patients with suspected membranous nephropathy: a survey study on medical practice after publication of Japanese Guidelines for Nephrotic Syndrome 2020. Clinical and Experimental Nephrology. 2024. (in press)
Yasushi Tsujimoto, Takuya Aoki, Sayaka Shimizu, Hiroo Kawarazaki, Kaori Kohatsu, Takeshi Nakata, Ann M. O’Hare, Yugo Shibagaki, Yosuke Yamamoto, Jun Miyashita. Perspectives on the optimal timing of advance care planning among Japanese patients undergoing dialysis and clinicians: a cross-sectional study. Clinical and Experimental Nephrology. 2024
Masahiro Koizumi, Takuji Ishimoto, Sayaka Shimizu, Sho Sasaki, Noriaki Kurita, Takehiko Wada. Japanese clinical practice patterns of rituximab treatment for minimal change disease in adults 2021: A web-based questionnaire survey of certified nephrologists. PloS one. 2024. 19. 3. e0299053
Yoshitaka Miyaoka, Noriaki Kurita, Tadashi Sofue, Hiroki Nishiwaki, Masahiro Koizumi, Sayaka Shimizu, Sho Sasaki, Takuji Ishimoto, Takehiko Wada. Practice patterns of rituximab for primary membranous nephropathy 2021 in Japan: a web-based survey of board-certified nephrologists. Clinical and experimental nephrology. 2023